Skip to main content
Clinical Trials/NCT06996522
NCT06996522Not yet recruitingNot Applicable

Underwater Endoscopic Mucosal Resection Versus Hot Snare Polypectomy in the Treatment of Pedunculated Colorectal Polyps Less Than 10mm in Size: A Single-center, Open-label, Randomized Controlled Trial

Fudan University1 site in 1 country338 target enrollmentStarted: June 1, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
338
Locations
1
Primary Endpoint
Post-polypectomy Bleeding

Study Overview

Brief Summary

A prospective, single-center, open-label, randomized controlled study to compare the effectiveness and safety of underwater endoscopic mucosal resection (UEMR) and hot snare polypectomy (HSP) in treating Pedunculated colorectal polyps less than 10mm in size.

Detailed Description

  1. Patients are undergone screening, surveillance, or therapeutic colonoscopy at the Endoscopy department of Gastrointestinal endoscopy center of Huadong hospital affiliated to Fudan University.
  2. Randomize patients with pedunculated colorectal polyps less than 10mm in size into 2 interventional groups based on Random function of Statistical Package for the Social Sciences (SPSS) 20.0, including (1) Group 1: Underwater endoscopic mucosal resection (UEMR) and (2) Group 2: Hot snare polypectomy (HSP).
  3. Collecting variables which consist of primary and secodary outcomes.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
35 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Aged between 35 and 80 years
  • •Pedunculated colorectal polyps less than 10mm in size in screening, surveillance or therapeutic colonoscopy
  • •0-Isp or 0-Ip according to Paris classification
  • •Patients must sign an informed consent form prior to registration in study

Exclusion Criteria

  • •Unsuitable for removal by UEMR or HSP
  • •Suspected malignancy
  • •History of inflammatory bowel disease or colorectal resection
  • •Familial adenomatous polyposis or Lynch syndrome
  • •Patients taking anticoagulant and antiplatelet agents before the examination
  • •Inadequate bowel preparation, defined as a Boston Bowel Preparation Scale score < 6
  • •Pregnancy or breastfeeding
  • •Severe comorbid disease involving the heart, lungs, liver, or kidneys.
  • •Concurrent serious conditions, including other active malignancies or severe infectious diseases

Arms & Interventions

UEMR in treating Pedunculated colorectal polyps less than 10mm in size

Experimental

The UEMR procedure included the following: (1) Water infusion to distend the intestinal lumen; (2) entrapment of the mucosal protrusion with a snare; and (3) resection using electrocautery

Intervention: underwater endoscopic mucosal resection (Procedure)

HSP in treating Pedunculated colorectal polyps less than 10mm in size

Active Comparator

The HSP procedure included the following: (1) entrapment and resection of the polyp with a snare with electrocautery.

Intervention: Hot snare polypectomy (Procedure)

Outcomes

Primary Outcomes

Post-polypectomy Bleeding

Time Frame: 2 weeks after the procedure

Presence of Clinically Significant Immediate Post-polypectomy Bleeding(CSIPB) or Clinically Significant Delayed Post-polypectomy Bleeding (CSDPB). CSIPB was defined as any bleeding not responding to water jet irrigation or STSC and therefore requiring either coagu lation forceps or mechanical clips to achieve hemostasis. CSDPB was defined as any bleeding after completion of the procedure requiring emergency room presentation, hospital isation or re-intervention (endoscopy, angiography, surgery).

Secondary Outcomes

  • Delayed perforation(2 weeks after the procedure)
  • en bloc resection(immediately after the procedure)
  • R0 resection(2 weeks after the procedure)
  • postoperative electrocoagulation syndrome(2 weeks after the procedure)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Zhijun Bao

Director

Fudan University

Study Sites (1)

Loading locations...

Similar Trials